arrow
H

Hirotoshi Watanabe

Hyogo Medical University
H指数:30
被引数:4,555

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy

无阿司匹林策略下质子泵抑制剂对经皮冠状动脉介入治疗患者的影响

2026-02-011
OAAI
Cardiac Damage Stages and Clinical Outcomes in Patients With Severe Aortic Stenosis
2026-01-011
OAAI
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

氯吡格雷与阿司匹林用于冠状动脉疾病二级预防:一项系统评价和个体患者数据meta分析

2025-08-310
PRE
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation

急性冠状动脉综合征伴高出血风险或ST段抬高1个月后阿司匹林与氯吡格雷的比较

2025-06-040
PRE
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
2025-01-250
OAAI
Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis

跨医院经导管主动脉瓣植入的可用性以及严重主动脉瓣狭窄患者的策略和临床结局的差异

2024-11-280
PRE
Concomitant Mitral Regurgitation in Severe Aortic Stenosis - Insights From the CURRENT AS Registry-2-

严重主动脉瓣狭窄伴二尖瓣反流-来自当前AS注册的见解-2-

2024-11-250
OA
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial
2024-10-231
PRE
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
2024-08-311
OA
Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial
2024-08-060
OAAI
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention

复杂经皮冠状动脉介入治疗后立即治疗的无阿司匹林策略

2024-05-013
PRE
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
2024-05-0123
PRE
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
2024-02-2048
PRE
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

基于急性冠状动脉综合征亚型和高出血风险的无阿司匹林经皮冠状动脉介入治疗的STOPDAPT-3试验

2024-01-295
PRE
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
2023-10-257
OA